Package Leaflet: Information for the User
Atorvastatina Cinfa 30 mg Film-Coated Tablets
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Atorvastatina Cinfa belongs to a group of medicines known as statins, which are medicines that regulate lipids (fats).
Atorvastatina Cinfa is used to reduce lipids such as cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes on their own have failed. If you present a high risk of heart disease, atorvastatina can also be used to reduce this risk even though your cholesterol levels are normal. During treatment, a standard low-cholesterol diet must be followed.
Do not take Atorvastatina Cinfa:
(listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before starting to take Atorvastatina Cinfa:
In any of these cases, your doctor may instruct you to have blood tests before and possibly during treatment with atorvastatin to predict the risk of suffering adverse effects related to muscle. It is known that the risk of suffering adverse effects related to muscle (e.g. rhabdomyolysis) increases when certain medicines are taken at the same time (see section 2 “Other medicines and Atorvastatina Cinfa”).
Also inform your doctor or pharmacist if you experience persistent muscle weakness. Additional tests and medications may be necessary to diagnose and treat this problem.
While taking this medicine, your doctor will monitor if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugars and fats in your blood, overweight, and high blood pressure.
Other medicines and Atorvastatina Cinfa
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.
There are some medicines that may affect the proper functioning of atorvastatin or the effects of these medicines may be modified by atorvastatin. This type of interaction may reduce the effect of one or both medicines. Alternatively, this combined use may increase the risk or severity of adverse effects, including the important muscle deterioration, known as rhabdomyolysis described in section 4:
Taking Atorvastatina Cinfa with food, drinks, and alcohol
See section 3 for instructions on how to take atorvastatin. Please note the following:
Orange juice
Do not take more than one or two small glasses of orange juice per day because large amounts of orange juice may alter the effects of atorvastatin.
Alcohol
Avoid drinking large amounts of alcohol while taking this medicine. See details in section 2 “Warnings and precautions”.
Pregnancy, breastfeeding, and fertility
Do not take atorvastatin if you are pregnant, think you may be pregnant, or are trying to become pregnant.
Do not take atorvastatin if you are fertile unless you take adequate contraceptive measures. Do not take atorvastatin if you are breastfeeding your child.
The safety of atorvastatin during pregnancy and breastfeeding has not been demonstrated.
Consult your doctor or pharmacist before using any medicine.
Driving and operating machinery
This medicine usually does not affect your ability to drive or operate machinery. However, do not drive if this medicine affects your ability to drive. Do not operate tools or machinery if this medicine affects your ability to handle them.
Atorvastatina Cinfa contains lactose and sucrose.
If your doctor has told you that you have a certain sugar intolerance, consult with him before taking this medicine.
Atorvastatina Cinfa contains sodium.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Before starting treatment, your doctor will put you on a low-cholesterol diet, which you must also follow during treatment with atorvastatina.
The recommended initial dose of atorvastatina is 10 mg once a day in adults and children aged 10 years and above. Your doctor may increase it if necessary to reach the dose you need. Your doctor will adjust the dose at intervals of 4 weeks or more. The maximum dose of atorvastatina is 80 mg once a day.
Atorvastatina tablets should be swallowed whole with a glass of water and can be taken at any time of the day with or without food. However, try to take your tablet every day at the same time.
Your doctor will decide the duration of treatment with Atorvastatina Cinfa
Ask your doctor if you think the effect of atorvastatina is too strong or too weak.
If you take more Atorvastatina Cinfa than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
Take the remaining tablets, the packaging, and the complete box so that hospital staff can easily identify the medication you have taken.
If you forget to take Atorvastatina Cinfa
If you forget to take a dose, take the next scheduled dose at the correct time. Do not take a double dose to make up for the missed doses.
If you interrupt treatment with Atorvastatina Cinfa
If you have any other questions about the use of this medication or want to discontinue treatment, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you notice any of the following side effects or severe symptoms, stop taking these tablets and inform your doctor immediately or go to the nearest hospital emergency service.
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Other possible side effects with Atorvastatina Cinfa
Frequent: may affect up to 1 in 10 people
Infrequent: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Frequency unknown: cannot be estimated from available data:
Consult your doctor if you experience weakness in the arms or legs that worsens after periods of activity, double vision or eyelid drooping, difficulty swallowing or difficulty breathing.
Possible side effects of some statins (medicines of the same type):
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
This medication does not require special conditions for conservation.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Atorvastatina Cinfa
Tablet core:Lactose monohydrate, Laurilsulfate of sodium, Butilhydroxyanisol (E-320), Crospovidone, Magnesium stearate, Microcrystalline cellulose (E-460), Anhydrous colloidal silica, Saccharose, Triesterate of sorbitan, Stearate of macrogol 40 (E-431), Dimethicone, Silica, 2, Bromo-2-Nitropropano-1,3-diol, Sodium bicarbonate.
Coating: Lactose monohydrate, Hypromelose (E-464), Titanium dioxide (E-171), Macrogol 4000.
Appearance of the product and contents of the packaging
The tablets are coated with a film, white, cylindrical, biconvex, and marked with the code “AT3”.
The packaging contains 28 tablets.
Holder of the marketing authorization and responsible for manufacturing
Cinfa Laboratories, S.A.
Carretera Olaz-Chipi, 10. Industrial Park Areta
31620 Huarte (Navarra) - Spain
Last review date of this leaflet:October 2024
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
QR code to:https://cima.aemps.es/cima/dochtml/p/85715/P_85715.html
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.